Rock Point Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Rock Point Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,285	Closed	-$236K	–	94
2022 Q4	$236K	Hold	3,285	–	–	0.08%	91
2022 Q3	$234K	Sell	3,285 -25	-0.8%	-$1.81K	0.09%	83
2022 Q2	$255K	Sell	3,310 -591	-15%	-$45K	0.09%	82
2022 Q1	$285K	Sell	3,901 -200	-5%	-$13.4K	0.09%	81
2021 Q4	$256K	Hold	4,101	–	–	0.07%	87
2021 Q3	$243K	Hold	4,101	–	–	0.07%	84
2021 Q2	$274K	Hold	4,101	–	–	0.08%	82
2021 Q1	$259K	Sell	4,101 -300	-7%	-$18.7K	0.08%	79
2020 Q4	$273K	Sell	4,401 -50	-1%	-$3.07K	0.09%	73
2020 Q3	$268K	Buy	4,451 +300	+7%	+$18.1K	0.12%	67
2020 Q2	$244K	Hold	4,151	–	–	0.11%	69
2020 Q1	$231K	Sell	4,151 -255	-6%	-$15.6K	0.14%	65
2019 Q4	$283K	Buy	+4,406	New	+$252K	0.11%	65

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Rock Point Advisors's BMY Position: Q1 2023 in Review

Rock Point Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2023, closing a stake of 3,285 shares — an estimated $236K sold.

Rock Point Advisors first reported a position in BMY in Q4 2019 and held it in 13 quarters. The position peaked at $285K in Q1 2022. 2,540 funds tracked by Wall St. Rank hold BMY as of Q1 2023.

Rock Point Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2023 after selling out during the quarter.
Rock Point Advisors sold 3,285 Bristol-Myers Squibb shares in Q1 2023, an estimated $236K.
Rock Point Advisors first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 13 quarters.
Rock Point Advisors's Bristol-Myers Squibb position peaked at $285K in Q1 2022.
2,540 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2023.

Based on Rock Point Advisors's 13F filing for Q1 2023, filed 10 May 2023.